Characteristics of the validation sample
| Anticoagulant (n=150) | Cardiac IP (n=120) | General medical IP (n=91) | Cardiac rehabilitation (n=44) | Asthma (n=153) | Diabetic insulin treated (n=65) | Diabetic OAA (n=112) | Oncology (n=91) | |
|---|---|---|---|---|---|---|---|---|
| IP = inpatients; OAA = oral antihypoglycaemic agents. | ||||||||
| *Asthma and diabetes data were collected in a single audit study with an average response rate of 82%. | ||||||||
| Response, n (%) | 121 (81) | 175 (83) | 38 (86) | (82)* | (82)* | (82)* | 83 (91) | |
| Male, n (%) | 91 (61) | 85 (71) | 46 (51) | 34 (77) | 64 (42) | 24 (37) | 76 (68) | 47 (52) |
| Mean (SD) age (years) | 67.5 (12.4) | 63.6 (12.4) | 54.0 (19.8) | 62.1 (9.9) | 45.8 (18.5) | 47.9 (17.0) | 58.2 (15.9) | 58.5 (15.8) |